Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

10.62USD
25 May 2018
Change (% chg)

$0.90 (+9.26%)
Prev Close
$9.72
Open
$9.74
Day's High
$10.94
Day's Low
$9.74
Volume
41,110
Avg. Vol
39,453
52-wk High
$11.19
52-wk Low
$2.81

Chart for

About

Aeglea BioTherapeutics, Inc. is a biotechnology company, which is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism (IEM) and cancer. The Company's product pipeline includes AEB1102, AEB3103, AEB2109 and AEB4104. Its lead product candidate, AEB1102,... (more)

Overall

Beta: --
Market Cap(Mil.): $232.14
Shares Outstanding(Mil.): 21.86
Dividend: --
Yield (%): --

Financials

  AGLE.OQ Industry Sector
P/E (TTM): -- 238.69 33.30
EPS (TTM): -1.83 -- --
ROI: -57.45 -7.54 13.04
ROE: -57.58 -10.33 14.90

BRIEF-Aeglea Biotherapeutics Announces Proposed Public Offering

* AEGLEA BIOTHERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Apr 17 2018

Earnings vs. Estimates